Cookies
Potrebujeme váš súhlas na využitie jednotlivých dát, aby sa vám okrem iného mohli ukazovať informácie týkajúce sa vašich záujmov. Súhlas udelíte kliknutím na tlačidlo „OK“.
ASTM E2524-08
Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles
Automaticky preložený názov:
Štandardná skúšobná metóda pre analýzu hemolytickou vlastností nanočastíc
NORMA vydaná dňa 1.2.2008
Informácie o norme:
Označenie normy: ASTM E2524-08
Poznámka: NEPLATNÁ
Dátum vydania normy: 1.2.2008
Kód tovaru: NS-45494
Počet strán: 5
Približná hmotnosť: 15 g (0.03 libier)
Krajina: Americká technická norma
Kategória: Technické normy ASTM
Anotácia textu normy ASTM E2524-08 :
Keywords:
hemolysis, nanoparticulate, plasma, whole blood, ICS Number Code 11.040.20 (Transfusion, Infusion), 71.100.01 (Products of the chemical industry in general)
Doplňujúce informácie
| Significance and Use | ||||||||||
| p>This test method is one of a series of tests listed in
Practice F 748 and ISO 10993-4 to assess the biocompatibility of
materials contacting blood in medical applications.
This test method is similar to Practice F 756 but modified to accommodate nanoparticulate materials. |
||||||||||
| 1. Scope | ||||||||||
|
1.1 This test method covers assessing the effect of nanoparticulate materials on the integrity of red blood cells. 1.2 This test method uses diluted whole blood incubated with nanoparticulate material and the hemoglobin released from damaged red blood cells is determined. 1.3 This test method is similar to Practice F 756 with the volumes reduced to accommodate nanoparticulate material. 1.4 This test method is part of the in-vitro preclinical characterization and is important for nanoparticulate material that will contact the blood in medical applications. 1.5 The values given in SI units are to be considered as the standard. 1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. |
||||||||||
| 2. Referenced Documents | ||||||||||
|
Doporučujeme:
